Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 6.38%49.96K | -0.59%55.51K | 3.88%57.35K | 3.19%208.07K | -44.71%50.06K | -2.43%46.96K | 8.88%55.84K | 372.15%55.21K | 1.46%201.64K | 84.83%90.53K |
| Selling and administrative expenses | 6.38%49.96K | -0.59%55.51K | 3.88%57.35K | -0.83%133.93K | -38.32%-24.08K | -2.43%46.96K | 8.88%55.84K | 4.08%55.21K | -32.05%135.05K | -135.55%-17.41K |
| -Selling and marketing expense | -34.46%1.69K | -6.66%2.83K | 12.32%4.75K | ---- | ---- | -25.39%2.58K | 38.54%3.03K | 45.49%4.23K | ---- | ---- |
| -General and administrative expense | 8.76%48.27K | -0.24%52.68K | 3.18%52.61K | -0.83%133.93K | -60.75%-14.24K | -0.66%44.38K | 7.56%52.8K | 1.68%50.99K | -28.21%135.05K | -119.61%-8.86K |
| Other taxes | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other operating expenses | ---- | ---- | ---- | 11.35%74.14K | ---- | ---- | ---- | ---- | --66.58K | ---- |
| Operating profit | -6.38%-49.96K | 0.59%-55.51K | -3.88%-57.35K | -3.19%-208.07K | 44.71%-50.06K | 2.43%-46.96K | -8.88%-55.84K | -372.15%-55.21K | -1.46%-201.64K | -84.83%-90.53K |
| Net non-operating interest income (expenses) | -17.71%-176.71K | -18.78%-169.95K | -17.81%-163.1K | -54.23%-591.31K | -19.65%-159.66K | -17.27%-150.12K | -130.90%-143.08K | -130.90%-138.44K | -73.05%-383.38K | -130.65%-133.44K |
| Non-operating interest expense | 17.69%176.64K | 18.77%169.9K | 17.81%163.06K | 54.23%591.31K | 19.61%159.76K | 17.28%150.09K | 131.00%143.04K | 131.01%138.41K | 73.05%383.38K | 130.37%133.57K |
| Total other finance cost | 160.00%78 | 31.58%50 | 22.58%38 | ---- | ---- | -21.05%30 | -15.56%38 | -26.19%31 | ---- | ---- |
| Other net income (expenses) | -6.46K | 53.44%-23.6K | 0 | |||||||
| Special income (charges) | ---6.46K | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 53.44%-23.6K | --0 |
| -Less:Other special charges | --6.46K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -53.44%23.6K | --0 |
| Income before tax | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Net income continuous operations | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Diluted earnings per share | 0.00%-0.01 | 0 | 0 | -33.33%-0.04 | -16.84%-0.01 | 3.17%-0.01 | 0 | 0 | 0.00%-0.03 | 12.29%-0.0086 |
| Basic earnings per share | 0.00%-0.01 | 0 | 0 | -33.33%-0.04 | 19.89%-0.01 | 3.17%-0.01 | 0 | 0 | 0.00%-0.03 | -27.93%-0.0125 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.